Evidence map›Paper›PMID 31518382›Full record

ArticlePloS one2019

The prevalence of asthma and allergic rhinitis in Nigeria: A nationwide survey among children, adolescents and adults.

Obianuju B Ozoh, Sunday A Aderibigbe, Adaeze C Ayuk, Olufemi O Desalu, Olufela E Oridota, Olajumoke Olufemi, Eruke Egbagbe, Musa Babashani, Azeezat Shopeyin, Kingsley Ukwaja and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2024
    Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2024
    Article
  13. Article
  14. A model to predict a risk of allergic rhinitis based on mitochondrial DNA copy number.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Obianuju B OzohDepartment of Medicine, College of Medicine, University of Lagos, Lagos State, Nigeria.ORCID 0000-0002-7865-4771
Sunday A AderibigbeDepartment of Public Health, College of Health Sciences, University of Ilorin, Kwara State, Nigeria.
Adaeze C AyukDepartment of Paediatrics, College of Medicine, University of Nigeria Teaching Hospital, Enugu State, Nigeria.
Olufemi O DesaluDepartment of Medicine, College of Health Sciences, University of Ilorin, Kwara State, Nigeria.
Olufela E OridotaLagos University Teaching Hospital, Lagos State, Nigeria.
Olajumoke OlufemiLagos University Teaching Hospital, Lagos State, Nigeria.
Eruke EgbagbeDepartment of Medicine, College of Medicine, University of Benin, Edo State, Nigeria.
Musa BabashaniDepartment of Medicine, College of Medicine, Aminu Kano University, Kano State, Nigeria.
Azeezat ShopeyinLagos University Teaching Hospital, Lagos State, Nigeria.
Kingsley UkwajaDepartment of Internal Medicine, Federal Teaching Hospital Abakiliki, Ebonyi State, Nigeria.
Sandra K DedeLagos University Teaching Hospital, Lagos State, Nigeria.
Lagos University Teaching Hospital · NGUniversity of Ilorin · NGUniversity of Lagos · NGAminu Kano Teaching Hospital · NGFederal Teaching Hospital Abakaliki · NGUniversity of Benin · NGUniversity of Nigeria Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAsthma is an important cause of morbidity and mortality worldwide and information on the prevalence of asthma in Nigeria is inconsistent. Nationally representative data, important for health planning is unavailable. We aimed to determine the current prevalence of asthma and allergic rhinitis in Nigeria. MATERIALS AND

methodsA cross-sectional population survey conducted between June 2017 and March 2018 across five cities representing five geo-political zones in Nigeria. Validated screening questionnaires were used to identify persons with asthma and allergic rhinitis respectively. Asthma was defined as physician diagnosed asthma, clinical asthma and by presence of wheeze in the last 12 months respectively. Socio-demographic information, tobacco smoking, sources of household cooking fuel were also obtained.

resultsA total of 20063 participants from 6024 households were screened. The prevalence (95% confidence interval) of physician diagnosed asthma, clinical asthma and wheeze was 2.5% (2.3-2.7%), 6.4% (6.0-6.64%) and 9.0% (8.6-9.4%) respectively. The prevalence of allergic rhinitis was 22.8% (22.2-23.4%). The prevalence of asthma and rhinitis increased with age (prevalence of clinical asthma: 3.1% (2.8-3.4%), 9.8% (9.1-10.5) and 10.7% (9.4%-12.0) among 6-17 years, 18-45 years and >45 years respectively). Prevalence also varied across different cities with the highest prevalence of clinical asthma occurring in Lagos (8.0%) and the lowest in Ilorin (1.1%). The frequency of allergic rhinitis among persons with clinical asthma was 74.7%. Presence of allergic rhinitis, family history of asthma, current smoking and being overweight were independent determinants of current asthma among adults.

conclusionThe prevalence of asthma and allergic rhinitis in Nigeria is high with variabilities across regions and age groups. The number of persons with clinical asthma in Nigeria (approximately 13 million) is likely to rank among the highest in Africa. This warrants prioritization by stakeholders and policy makers to actively implement risk reduction measures and increase investment in capacity building for the diagnosis and treatment of asthma and allergic rhinitis.

Indexed as

AdolescentAdultAgedAged, 80 and overAsthmaChildCross-Sectional StudiesFemaleHumansMaleMiddle AgedMorbidityNigeriaPrevalenceRhinitis, AllergicRisk Factors

Identifiers

PMID31518382
PMCPMC6743776
OpenAlexW2972416813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.